January 25, 2019 10:15
As the cost of genome sequencing decreases, researchers and clinicians are debating whether all newborns should be sequenced at birth to facilitate a lifetime of personalized medical care. What if everyone had access to their genomic health data?
Join an in-depth discussion that explores the possible, plausible and probable impacts of genome sequencing at birth.
This session will be livestreamed on TopLink and the Forum website.
Speakers:
Stéphane Bancel
Chief Executive Officer, Moderna
Jay Flatley
Digital Member
Jodi Halpern
Professor of Bioethics and Medical Humanities, University of California, Berkeley
Matt Hancock
Secretary of State for Health and Social Care, Department of Health and Social Care of the United Kingdom
Elizabeth ODay
Alumni, Global Shapers Community